Product
Review: Ginkgo Biloba and Huperzine A — Memory Enhancers
Initial Posting: 4/21/03
What It Is:
Ginkgo biloba in dietary supplements is typically an extract made from
leaves of the Ginkgo biloba tree and containing many phytochemicals.
Huperzine A, in dietary supplements, is a chemical purified from leaves
of the Chinese toothed club moss (Huperzia serrata (Thunb. ex
Murray) Trevis) or synthetically manufactured.
What It Does: Ginkgo biloba:
Ginkgo biloba has become a widely used dietary supplement for increasing
cognitive functions in elderly people, delaying the progression of
Alzheimer's disease, increasing blood flow to the legs, treating
tinnitus (ringing in the ear) of a circulatory origin, as well as
treating depression and asthma.
Huperzine A:
Huperzine A, based on limited studies, has been shown to improve memory,
thinking, and behavioral function in people with Alzheimer's disease,
multi-infarct dementia, and senile dementia.. It is believed to work in
a manner similar to some prescription drugs for treating symptoms of
Alzheimer's disease: increasing the level of the neurotransmitter
acetylcholine by blocking its breakdown. It may also protect neurons
from cell death caused by toxic levels of glutamate and protect against
some of the effects of chemical nerve agents used in warfare, such as
soman.
Quality Concerns and What CL Tested for: Ginkgo Biloba:
The Ginkgo biloba extract, or GBE, used in most clinical trials contains
particular phytochemicals: Flavonol glycosides, of which there are three
basic types, are believed to confer anti-oxidant activity; Terpene
lactones, of which there are two basic types, may be responsible for the
dilatory effect on blood vessels. One specific terpene lactone called
bilobalide, may also increase brain activity through an effect on GABA
receptors. Specifically, the GBE shown to work in clinical trials has
contained at least 5% terpene lactones (consisting of bilobalide (2.6%)
and ginkgolides A, B and C (2.8%)) and at least 22% flavonol glycosides
(consisting of quercetin (9.5%), kaempferol (10.5%), and isorhamnetin
(2.0%).
Many GBE products now claim to be "standardized" or manufactured to
contain specific total amounts of flavonol glycosides and/or total
terpene lactones, but few claim to have specific amounts of the
individual compounds, such as bilobalide. However, ConsumerLab.com's
review of GBE products in 1999 found that nearly one quarter of the
thirty brands tested did not have the expected levels of chemical
marker compounds for GBE, despite claims to have been "standardized."
Huperzine A:
Only the (-) isomer of huperzine A is active. However, if a product is
made from synthetic huperzine A, at least 50% of its huperzine A
will be inactive, and often products do not state the form of huperzine
A that they contain. The labeled amount of huperzine A of a product
should reflect only the active form. Huperzine A is also a relatively
expensive ingredient, creating an economic incentive for making a
product with less than the labeled amount.
Lead in Natural Products:
Lead is a potential contaminant in natural products. In children,
infants, and fetuses, even low levels of lead can adversely affect
neurobehavioral development and cognitive function. In adults, lead at
somewhat higher levels can cause elevated blood pressure, anemia, and
adversely affect the nervous and reproductive systems. Lead is of
particular concern during pregnancy as the mother can transfer it to the
fetus.
Currently, there is no government monitoring of the manufacture of
dietary supplements in the U.S. In order to help consumers identify
products of better quality, ConsumerLab.com purchased and tested many
Ginkgo biloba and huperzine A products and tested them for the quality
of their ingredients and lead levels. In addition, products in tablet
form were tested for their ability to properly disintegrate in solution
— which is necessary for their ingredients to be absorbed.
What CL Found
ConsumerLab.com purchased nine brands of Ginkgo biloba and four brands
of huperzine A in December 2002 and January 2003 In testing, seven
of the nine ginkgo products were found to lack adequate levels of one or
more important compounds expected of clinically effective ginkgo. Many
of these products claimed to be standardized for total terpene
lactones and/or flavonol glycosides and did, in fact, meet these totals
but did not have the right amount of one or more individual
terpene lactones and flavonol glycosides. In fact, 6 products had less
than one-fifth of the expected amount of bilobalide, a type of terpene
lactone that may be particularly important to ginkgo's effectiveness.
Bilobalide has specifically been shown to interact with GABA receptors
and enhance the excitability of neurons in the hippocampus of the brain,
which is associated with learning and memory.
All of the huperzine A products were found to contain their claimed
amount of huperzine A in the active (-) isomer form. However, one
product contained an unacceptable amount of lead.
All products in tablet form were found to disintegrate properly in
solution, as needed for absorption in the gut.
Test Results by Product:
Listed alphabetically in the table below are the products that were
tested and a summary of their results. Products that met all of
ConsumerLab.com's Passing Score criteria are indicated as "Approved
Quality" and are listed first in their category. Also included in the
list are other products that have met the same criteria through CL's
Voluntary Certification Program (these are indicated with an asterisk).
CONSUMERLAB.COM RESULTS FOR GINKGO BILOBA AND HUPERZINE A
PRODUCTS
Name of Product and Claimed Amount of Ingredient per Unit
Manufacturer or Distributor
Test Results
(Based on Product's Suggested Daily Serving)
GINKGO BILOBA:
(Amounts shown are as Ginkgo Biloba Extract)
HUPERZINE A:
(Amounts shown are as huperzine A in (-) isomer form)
Expected
Huperzine A
( (-) isomer)
Lead Level
(2 micrograms or less)
Approved Quality:
Amerifit™ Nutrition
Natural Mind Support Huperzine A, Quality Standardized Herbal
Extracts, 50 mcg/tablet
Dist. by Amerifit™
Nutrition
Nutra Pharm Huperzine
A, Standardized Extract from Chinese Club Moss, with Vitamin E, 50
mcg/capsule
Dist. by Nutra Pharm
Pro Health™ Huperzine
A, 50 mcg/tablet
Dist. by Pro Health,
Inc
Not
Approved Quality:
Solaray® Dietary
Supplement, Guaranteed Potency Hup A, From Chinese Moss, 50 mcg/
capsule
Mfd. by Nutraceutical
Corp.
Exceeded 2 micrograms
*Tested through CL's
Voluntary Certification Program prior to, at time of, or after the
posting of this Product Review.
**Total and specific
terpene lactones (bilobalide and ginkgolides) and flavonol
glycosides (quercetin, kaempferol, and isorhamnetin). See Passing
Score for more information. Explanation gives primary reason for not
achieving Passing Score.
Unless otherwise noted,
information about the products listed above is based on the samples
purchased by ConsumerLab.com for this Product Review. Manufacturers
may change ingredients and label information at any time, so be sure
to check labels carefully when evaluating the products you use or
buy. If a product's ingredients differ from what is listed above, it
may not necessarily be of the same quality as what was tested.
What to Consider When Buying: Ginkgo biloba:
Consumers seeking products most similar to those used in clinical
studies should seek those containing Ginkgo biloba leaf extract (GBE).
The plant chemicals in the extract are about 50 times more concentrated
than in dried ginkgo leaf, so be sure to look for an extract. The
extract should also be standardized for the specific compounds tested
for in this study. This is often summarized as 24% flavonol glycosides
and 6% terpene lactones, or in terms of milligrams for a 40 mg pill, for
example, 9.6 mg and 2.4 mg, of each respectively. Although rarely listed
on labels, products should ideally also be standardized for the
following specific flavonol glycosides and terpene lactones: quercetin
(minimum 9.5%), kaempferol (minimum 10.5%), isorhamnetin (minimum 2.0%),
ginkgolides A, B, C (minimum 2.8%), and bilobalide (minimum 2.6%).
Huperzine A:
The active form of huperzine A is the (-) isomer, which is the form that
occurs naturally in Chinese club moss. Synthetic huperzine will contain
a mixture of huperzine A in the active (-) isomer form and the inactive
(+) isomer form. Consequently, if a product does not claim to be
natural, be sure that label states the amount of huperzine specifically
in the active (-) isomer form.
To assist consumers, manufacturers of products that passed
ConsumerLab.com testing are eligible to display ConsumerLab.com's
flask-shaped Seal of Approval which reads "APPROVED QUALITY — GINKGO
BILOBA or HUPERZINE A" (see
The CL Seal) on their
labels. ConsumerLab.com will periodically retest these and other
products for quality.
What to Consider When Using: Ginkgo biloba:
A total daily dose of 120 mg of GBE (taken in doses of 40 mg or 60 mg
over the course of the day, not at once) is generally recommended to
achieve effects, which may take several weeks before onset. European
health authorities recommend a daily dosage of up to 240 mg per day for
more severe cases.
Huperzine A:
Doses of 50 to 200 mcg (micrograms) twice daily have been used
for Alzheimer's disease and multi-infact dementia, and a somewhat lower
dose of 30 mcg twice daily has been used for senile or presenile
dementia. A dose of 100 mcg twice daily has been used for memory
improvement in adolescents. Some studies suggest huperzine A may enhance
the effects of prescription drugs donepezil (Aricept) or tacrine (Cognex),
permitting lower doses of these drugs and fewer side effects from them.
Concerns and Cautions: Ginkgo biloba:
Consumers may want to check with their healthcare professional before
using Ginkgo biloba — especially if it is being taken to treat a
potentially serious medical condition. Like many pharmacologically
active herbs and other dietary supplements, potential interactions can
occur with other nutrients or drugs, particularly the blood-thinning
drug coumadin or aspirin. In a small percentage of individuals, ginkgo
may produce some unwanted side effects (particularly in high doses) such
as nervousness, headache, and stomach-ache.
Huperzine A:
Because huperzine A increases acetylcholine levels, it may decrease the
effectiveness of anticholinergic drugs (such as atropine, Cogentin,
Akineton, Kemadrin, and Artane) and its own effectiveness may reduced if
used with such drugs. Conversely, it may increase the activity of other
cholinergic drugs and acetylcholinesterase inhibitors such as Urecholine,
Aricept, phospholine iodine, Enlon, Reversol, Tensilon, Prostigmin,
Antilirium, Mestinon, Regonol, Anecitne, Quelicin, and Cognex. Consult a
physician before using huperzine A with any of these drugs.
Huperzine A can decrease heart rate and must be used with caution in
patients with heart problems. Theoretically, huperzine A may exacerbate
gastrointestinal and urinary obstruction, peptic ulcer disease, asthma,
and chronic obstructive pulmonary disease.
Information on this site is provided for informational purposes
only. It is not an endorsement of any product nor is it meant to
substitute for the advice provided by physicians or other healthcare
professionals. The information contained herein should not be used for
diagnosing or treating a health problem or disease.